NEU 6.41% $15.27 neuren pharmaceuticals limited

Ann: FDA approves Daybue - the first treatment for Rett syndrome, page-65

  1. 2,168 Posts.
    lightbulb Created with Sketch. 571
    my take is these are the sales thresholds, once they are met it triggers the appropriate royalties/milestones
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.